Oncodesign Services receives global excellence award – Oncology CRO of the year 2024 – FRANCE
We are incredibly proud to announce that we have been recognized for our dedication to excellence in drug discovery and preclinical research by the Global Health & Pharma Magazine with the global excellence award – Oncology CRO – France for 2024. This award is a statement to our contributions to oncology research.
It follows last year’s award for “Best Preclinical Services and Drug Discovery Company – FRANCE“.
These awards reflect our commitment to excellence and the trust our clients place in us. They highlight the success of our capabilities, combining in vitro and in vivo expertise, and the efforts of our multidisciplinary teams.
Choosing Oncodesign Services is a key to excellence and innovation.
Together, we can unlock the potential of your R&D program.
Get in touch today via the contact page!
